A case report of pediatric fulminant hepatitis treated with plasma diafiltration

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 4, 2008, Pages 329-332

  Nakae, Hajime ^a   Igarashi, Toshiko ^a   Tajimi, Kimitaka ^a   Noguchi, Atsuko ^a   Takahashi, Ikuko ^a   Tsuchida, Satoko ^a   Takahashi, Tsutomu ^a   Asanuma, Yoshihiro ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fulminant hepatitis; Pediatric; Plasma diafiltration; Plasma exchange

Indexed keywords

ALBUMIN; BILIRUBIN; CYSTATIN C; INTERLEUKIN 18;

ADOLESCENT; ARTICLE; ARTIFICIAL KIDNEY; BILIRUBIN BLOOD LEVEL; CASE REPORT; CONVALESCENCE; DIALYSATE; FLOW RATE; HEMODIAFILTRATION; HEPATIC ENCEPHALOPATHY; HEPATITIS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FAILURE; LIVER REGENERATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING;

ADOLESCENT; ALBUMINS; BILIRUBIN; CYSTATINS; HEMODIAFILTRATION; HEPATITIS B; HUMANS; INTERLEUKIN-18; LIVER FAILURE, ACUTE; MALE; PLASMA;

EID: 49249101250     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2008.00595.x     Document Type: Article

References (13)

1. Mori T, Eguchi Y, Shimizu T et al. A case of acute hepatic insufficiency treated with novel plasmapheresis plasma diafiltration for bridge use until liver transplantation. Ther Apher 2002 6: 463 6.
2. Nakae H, Igarashi T, Tajimi K et al. A case of hepatorenal syndrome treated with plasma diafiltration. Ther Apher Dial 2007 11: 391 5.
3. Nakae H, Tajimi K. Pharmacokinetics of nafamostat mesilate during continuous hemodiafiltration with a polyacrylonitrile membrane. Ther Apher Dial 2003 7: 483 5.
4. Nakae H, Igarashi T, Tajimi K. The dose of nafamostat mesilate during plasma exchange with continuous hemodiafiltration in the series-parallel circuit. Ther Apher Dial 2006 10: 233 6.
5. Shimizu-Tokiwa A, Kobata M, Io H et al. Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine. Nephron 2002 92: 224 6.
6. Tsutsui H, Adachi K, Seki E, Nakanishi K. Cytokine-induced inflammatory liver injuries. Curr Mol Med 2003 3: 545 59.
7. Nakae H, Asanuma Y, Tajimi K. Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients. Ther Apher 2002 6: 419 24.
8. Nakae H, Zheng YJ, Wada H, Tajimi K, Endo S. Involvement of IL-18 and soluble Fas in patients with postoperative hepatic failure. Eur Surg Res 2003 35: 61 6.
9. Nakae H, Yonekawa C, Moon S, Tajimi K. The series-parallel circuit in the treatment of fulminant hepatitis. Ther Apher Dial 2004 8: 153 9.
10. Yonekawa C, Nakae H, Tajimi K, Asanuma Y. Effectiveness of combining plasma exchange and continuous hemodiafiltration in patients with postoperative liver failure. Artif Organs 2005 29: 324 8.
11. Lowrie LH. Renal replacement therapies in pediatric multiorgan dysfunction syndrome. Pediatr Nephrol 2000 14: 6 12.
12. Singer AL, Olthoff KM, Kim H, Rand E, Zamir G, Shaked A. Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg 2001 234: 418 24.
13. Debray D, Yousef N, Durand P. New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients. Paediatr Drugs 2006 8: 1 13.